紀要論文 EGFR-TKI Versus Chemotherapy for Previously Untreated Advanced Non-Small Cell Lung Cancer in Asians: A Meta-Analysis

ANDO Koichi:筆頭著者:責任著者  ,  KUSUMOTO Sojiro  ,  TANAKA Akihiko  ,  YAMAOKA Toshimitsu  ,  OHMORI Tohru  ,  OHNISHI Tsukasa  ,  INOUE Shin  ,  SAGARA Hironori

29 ( 4 )  , pp.435 - 443 , 2017-12 , Showa University Society
ISSN:0915-6380
内容記述
We comparatively assessed the overall efficacies of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy for previously untreated, EGFR mutation-positive, advanced non-small cell lung cancer in Asians through a meta-analysis of relevant phase-3 trials. The primary and secondary outcomes were overall survival (OS) and progression-free survival (PFS), respectively. Pooled estimates were calculated as hazard ratios (HRs) with 95% confidence intervals (CIs). Seven studies on EGFR-TKIs met the inclusion criteria for this study. The HRs and 95% CIs for OS and PFS for EGFR-TKIs, relative to chemotherapy, were 0.98 (0.77–1.24) and 0.32 (0.24–0.43), respectively. We found no difference in overall efficacy between EGFR-TKIs and chemotherapy in terms of OS, although the median PFS with EGFR-TKI was superior to that with chemotherapy among Asians with previously untreated, EGFR mutation-positive, advanced non-small cell lung cancer (UMIN ID: UMIN28424).
本文を読む

http://lilitory.showa-u.ac.jp/?action=repository_uri&item_id=4736

https://lilitory.showa-u.ac.jp/?action=repository_action_common_download&item_id=4736&item_no=1&attribute_id=38&file_no=1

このアイテムのアクセス数:  回

その他の情報